Durham-based integrated contract development and manufacturing organization (CDMO), Scorpius Holdings, Inc.(NYSE American: SCPX), has recently closed its underwritten public offering, generating a total of $14.4 million in gross proceeds.With the full exercise of the underwriters’ over-allotment option, the company issued a total of 14,375,000 shares of common stock and/or pre-funded warrants to interested investors.This successful offering marks a significant milestone for Scorpius as it continues to expand its operations in the market.
Context:Before the public offering, Scorpius Holdings, Inc.had approximately 28.18 million shares outstanding.As of now, the current price per share stands at $1.09.This means that the public offering of 14,375,000 shares at a price of $1.00 per share (inclusive of the pre-funded warrant exercise price) allows Scorpius to raise fresh capital to fuel its growth plans.Scorpius Holdings, a leading integrated contract development and manufacturing organization (CDMO), recently concluded its underwritten public offering, raising $14.4 million in gross proceeds.The offering involved the issuance of 14,375,000 shares of common stock, including the full exercise of the underwriters’ over-allotment option.
The public offering was priced at $1.00 per share, which factored in the pre-funded warrant exercise price.This allowed Scorpius to generate significant funds to support its ongoing operations and fuel its growth strategy.The company will deduct underwriting discounts and offering expenses from the total gross proceeds.
Scorpius Holdings, Inc. based in Durham, North Carolina, has swiftly emerged as a key player in the CDMO industry, providing comprehensive contract development and manufacturing services to various sectors, including pharmaceuticals, biotechnology, and medical devices.The successful completion of this public offering demonstrates investor confidence in Scorpius’ business model and future prospects.
The offering is expected to offer the company increased financial flexibility to accelerate its expansion plans, invest in research and development capabilities, and drive technological advancements.Scorpius aims to strengthen its market position and capitalize on the growing demand for contract development and manufacturing services.
Before the public offering, Scorpius Holdings, Inc.had approximately 28.18 million shares outstanding.With the completion of the underwritten public offering, the company now has an increased equity base, enabling it to pursue strategic acquisitions, explore new markets, and drive organic growth.
The closing price for Scorpius Holdings, Inc.currently stands at $1.09 per share, reflecting the market’s positive outlook on the company’s future prospects.This recent influx of capital will allow Scorpius to invest in state-of-the-art facilities, hire top talent, and expand its service offerings to cater to the evolving needs of its diverse clientele.
In conclusion, Scorpius Holdings, Inc.has successfully concluded its underwritten public offering, raising $14.4 million in gross proceeds.With an increased equity base, the company is well-positioned to pursue its growth plans, enhance its market presence, and provide innovative solutions to its clients in the CDMO sector.
Comments